Melbourne Clinical Trials
The Rhythm Study
The study drug is a potential new treatment for paroxysmal atrial fibrillation (pAF).
2 nights
3 screening visits + 2 Phone Calls visits
Atrial fibrillation (AF) is a condition that causes the heart to beat fast and irregularly. Paroxysmal AF is a type of AF that is intermittent (starts and stops). The study drug is a new form of an already approved medication that will be administered in a low dose (2 inhalations) using a nebulizer.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Male or Female
Age 18-70 years old
BMI 18 - 35kg/m²
Weight between 60 - 120kg
Medical History No significant medical history
Medication Not taking any medication
Smoking History Smoking, must be willing to abstain for the duration of the study.